Retrospective Analysis of Acute Pancreatitis After Percutaneous Mechanical Thrombectomy In Treatment Of Thrombotic Disorders
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRenJi Hospital
About this trial
Acute pancreatitis is a rare complication after percutaneous mechanical thrombectomy in treatment of thrombotic disorders. The objectives of this study include: (1) Determine the incidence and severity of acute pancreatitis after percutaneous mechanical thrombectomy; (2) Identify patient/procedural risk factors; (3) Evaluate clinical outcomes; (4) Develop a diagnosis and treatment pathway.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients over 18 years old;
Patients with thrombotic peripheral vascular diseases treated by percutaneous mechanical thrombectomy;
Patients developed acute pancreatitis within 14 days after percutaneous mechanical thrombectomy;
Patients with written informed consent.
Disqualifiers
Patients with acute pancreatitis attributed to other confirmed causes;
Patients unable or unwilling to participate in the study.
Trial population
Patients with acute pancreatitis after percutaneous mechanical thrombectomy for thrombotic disorders
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
10 Participants
are grouped into 1 trial groupGroup A: Acute pancreatitis after percutaneous mechanical thrombectomy group
Trial outcomes
Primary outcomes
1
Incidence of acute pancreatitis
The incidence of acute pancreatitis within 14 days after mechanical thrombectomy for peripheral thromboembolic disease.
Time frame
Within 14 daysSecondary outcomes
1
Incidence of acute severe pancreatitis
The incidence of acute severe pancreatitis within 14 days after mechanical thrombectomy for peripheral thromboembolic disease.
Time frame
Within 14 daysOther outcomes
1
Admission to intensive care unit rate
Safety outcomes: Admission to intensive care unit rate within 60 days after mechanical thrombectomy for peripheral thromboembolic disease
Time frame
Within 60 days2
All-cause mortality rate
Safety outcomes: All-cause mortality rate within 60 days after mechanical thrombectomy for peripheral thromboembolic disease during hospitalization
Time frame
within 60 daysSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov